210 related articles for article (PubMed ID: 8853808)
1. Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system.
Tani N
Artif Organs; 1996 Aug; 20(8):922-9. PubMed ID: 8853808
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits.
Yamamoto T; Yamashita T
Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis.
Yavasoglu I; Kadikoylu G; Bolaman Z
Ther Apher Dial; 2008 Feb; 12(1):100-1; author reply 102. PubMed ID: 18257822
[No Abstract] [Full Text] [Related]
5. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis.
Yoshidome H; Kuriyama M; Fujiyama J; Osame M
Artif Organs; 1998 Feb; 22(2):144-8. PubMed ID: 9491906
[TBL] [Abstract][Full Text] [Related]
7. LDL apheresis in atherosclerotic disease with hyperlipidemia.
Naganuma S; Agishi T; Ota K
ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
[TBL] [Abstract][Full Text] [Related]
8. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
Bambauer R; Schiel R; Latza R
Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
[TBL] [Abstract][Full Text] [Related]
9. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
[TBL] [Abstract][Full Text] [Related]
10. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
11. Dextran-sulfate cellulose adsorption for lowering Lp[a].
Parker TS
Chem Phys Lipids; 1994 Jan; 67-68():331-8. PubMed ID: 8187231
[TBL] [Abstract][Full Text] [Related]
12. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
Sosland RP; Gollub SB; Wilson DB; Moriarty PM
Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
[TBL] [Abstract][Full Text] [Related]
13. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
[TBL] [Abstract][Full Text] [Related]
14. Application of a new LDL apheresis system using two dextran sulfate cellulose columns in combination with an automatic column-regenerating unit and a blood cell separator.
Knisel W; Müller M; Besenthal I; di Nicuolo A; Rebstock M; Risler T; Eggstein M
J Clin Apher; 1991; 6(1):11-5. PubMed ID: 2045376
[TBL] [Abstract][Full Text] [Related]
15. Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.
Wang JW; Zhang YN; Sze SK; van de Weg SM; Vernooij F; Schoneveld AH; Tan SH; Versteeg HH; Timmers L; Lam CSP; de Kleijn DPV
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286309
[TBL] [Abstract][Full Text] [Related]
16. LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia.
Bambauer R; Schiel R; Latza R; Klinkmann J; Schneidewind JM
Ther Apher; 1997 Feb; 1(1):49-54. PubMed ID: 10225781
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
[TBL] [Abstract][Full Text] [Related]
18. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
[TBL] [Abstract][Full Text] [Related]
19. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
20. In vitro, in vivo studies of a new amphiphilic adsorbent for the removal of low-density lipoprotein.
Cheng Y; Wang S; Yu Y; Yuan Y
Biomaterials; 2003 Jun; 24(13):2189-94. PubMed ID: 12699654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
